Zhan P, Wang Y, Zhao S, Liu C, Wang Y, Wen M, Mao J-H, Wei G, Zhang P.  2015.  FBXW7 negatively regulates ENO1 expression and function in colorectal cancer.. Lab Invest. 95(9):995-1004.

Zhang P, Lo A, Huang Y, Huang G, Liang G, Mott J, Karpen GH, Blakely EA, Bissell MJ, Barcellos-Hoff MHelen et al..  2015.  Identification of genetic loci that control mammary tumor susceptibility through the host microenvironment.. Sci Rep. 5:8919.

Wang Y, Wen M, Kwon Y, Xu Y, Liu Y, Zhang P, He X, Wang Q, Huang Y, Jen K-Y et al..  2014.  CUL4A induces epithelial-mesenchymal transition and promotes cancer metastasis by regulating ZEB1 expression.. Cancer Res. 74(2):520-31.

Wang Y, Zhang P, Liu Z, Wang Q, Wen M, Wang Y, Yuan H, Mao J-H, Wei G.  2014.  CUL4A overexpression enhances lung tumor growth and sensitizes lung cancer cells to erlotinib via transcriptional regulation of EGFR.. Mol Cancer. 13:252.

Wang Z, Liu Y, Zhang P, Zhang W, Wang W, Curr K, Wei G, Mao J-H.  2013.  FAM83D promotes cell proliferation and motility by downregulating tumor suppressor gene FBXW7.. Oncotarget. 4(12):2476-86.

Wang Y, Liu Y, Lu J, Zhang P, Wang Y, Xu Y, Wang Z, Mao J-H, Wei G.  2013.  Rapamycin inhibits FBXW7 loss-induced epithelial-mesenchymal transition and cancer stem cell-like characteristics in colorectal cancer cells.. Biochem Biophys Res Commun. 434(2):352-6.

Wei G, Wang Y, Zhang P, Lu J, Mao J-H.  2012.  Evaluating the prognostic significance of FBXW7 expression level in human breast cancer by a meta-analysis of transcriptional profiles.. J Cancer Sci Ther. 4(9):299-305.